| Betsy Reinstein Dewey, | |
|
4618 Derussey Pkwy, Chevy Chase, MD 20815-5332 | |
| (301) 718-0262 | |
| Not Available |
| Full Name | Betsy Reinstein Dewey |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4618 Derussey Pkwy, Chevy Chase, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457951618 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 25186 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Betsy Reinstein Dewey, 4618 Derussey Pkwy, Chevy Chase, MD 20815-5332 Ph: (301) 718-0262 | Betsy Reinstein Dewey, 4618 Derussey Pkwy, Chevy Chase, MD 20815-5332 Ph: (301) 718-0262 |
News Archive
InflaRx announced today the successful completion of its recent clinical phase I study investigating its lead drug candidate IFX-1, a new first in class monoclonal antibody inhibiting complement driven inflammation. The trial reached its anticipated endpoints, demonstrating that IFX-1 is safe and well tolerated while displaying desirable PK and PD parameters.
The middle classes from developing countries are more susceptible than western Caucasians to obesity, type 2 diabetes and cardiovascular disease in today's changing environment. New research published today in Cell Metabolism from the University of Sydney in Australia, the National Centre for Cell Science and the DYP Medical College in Pune, India reveals this may be a result of the nutrition endured by their ancestors.
In its most frightening version to date, the new Big Lie about health care reform is that it will require the Internal Revenue Service to hire "16,500 armed bureaucrats" to enforce the coming requirement that those who can afford it must purchase insurance (Eric Zorn, 4/8).
Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
› Verified 7 days ago
Nancy Paulette Harazduk, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5480 Wisconsin Ave, Chevy Chase, MD 20815 Phone: 301-793-4033 | |
Dr. Melvin Alan Shandler, PH.D. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3102 Woodhollow Dr, Chevy Chase, MD 20815 Phone: 301-652-3610 Fax: 301-652-6221 | |
Diane Okoneski, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5480 Wisconsin Ave Lowr Level-8, Chevy Chase, MD 20815 Phone: 301-593-1618 | |
Mary Eccles, PHD, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3407 Raymond St, Chevy Chase, MD 20815 Phone: 301-907-0914 | |
Ms. Mary C Schwartz, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4619 Chevy Chase Blvd, Chevy Chase, MD 20815 Phone: 301-657-3765 | |
Mrs. Diana B Seasonwein, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 5480 Wisconsin Ave, Suite 222, Chevy Chase, MD 20815 Phone: 202-412-9020 Fax: 202-244-2823 | |
Patricia Garcia Golding, LCSW C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5480 Wisconsin Ave, Suite 227, Chevy Chase, MD 20815 Phone: 301-907-7888 |